Healthcare Industry News: RaySearch Laboratories
News Release - October 3, 2011
RaySearch Laboratories AB: Florida hospital selects RayStation(R)STOCKHOLM--(Healthcare Sales & Marketing Network)-- RaySearch Laboratories AB (STO:RAYB.st ) has received an order for its RayStation® treatment planning system from Baptist Hospital of Miami.
Baptist Hospital of Miami is a part of Baptist Health South Florida which is the largest faith-based, not-for-profit health care organization in the region, with an outstanding reputation for medical and service excellence.
The hospital will primarily use RayStation® as its treatment planning system for advanced treatments, such as IMRT. The order includes multi-criteria optimization which is an advanced product enabling a more efficient treatment planning process. This highly intuitive tool lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming treatment planning optimization process.
“Having Baptist hospital as our first customer in Florida is a great step as we begin to broaden our geographical coverage. We look forward to working with such a skilled department to implement RayStation® and help them in their quest to provide the highest standard of cancer care,” says Marc Mlyn, President of RaySearch Americas.
Johan Löf, CEO of RaySearch Laboratories AB adds: “This order is a sign of the growing interest for RayStation® we see in the US right now. Last week the first patient was treated with RayStation® in Boston and now we received our first order from the Southeast region of the US. We will continue to work hard to keep expanding in the US as well as on other markets.”
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for both photon and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian, TomoTherapy and Siemens. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.
Source: RaySearch Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.